TY - JOUR
T1 - Studies of the Pro12Ala polymorphism of the PPAR-γ gene in the Danish MONICA cohort
T2 - Homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome
AU - Frederiksen, Laura
AU - Brødbæk, Kasper
AU - Fenger, Mogens
AU - Jørgensen, Torben
AU - Borch-Johnsen, Knut
AU - Madsbad, Sten
AU - Urhammer, Søren A.
PY - 2002/8/24
Y1 - 2002/8/24
N2 - The Pro12Ala polymorphism of PPAR-γ2 has been shown to influence insulin sensitivity and the risk of type 2 diabetes in various ethnic populations. We examined whether the polymorphism was related to the insulin resistance syndrome (IRS) among nondiabetic Danish subjects. The Pro12Ala variant was examined using PCR-restriction fragment length polymorphism in a phenotypically well characterized population-based sample of 2245 nondiabetic subjects. The study participants were characterized by a number of anthropometric and biochemical measurements and the European Group for the Study of Insulin Resistance criteria enabling a classification of the study population in an IRS group and a non-IRS group. The allelic frequency of the Pro12Ala polymorphism in the total study sample was 14% (95% confidence interval, 13-15%). Two hundred ninety-four subjects fulfilled the European Group for the Study of Insulin Resistance criteria defining the IRS. The frequency of the Ala allele was 12.6% in the IRS group and 14.2% among subjects classified as not having the IRS (P = 0.15). However, the frequency of the variant in the homozygous form was significantly lower in the IRS group [0.7% (0-1.6%)] compared with the frequency in the non-IRS group [2.8% (2.1-3.5%); P = 0.02; odds ratio, 0.24 (0.06-0.99)]. Moreover, in the total study population, homozygous carriers of the variant had lower levels of fasting serum triglyceride [1.1 ± 0.4 mmol/liter (means ± SD) vs. 1.4 ± 0.9 mmol/liter; P = 0.04] and a lower diastolic blood pressure (79 ± 8 mm Hg vs. 82 ± 11 mm Hg; P = 0.01) compared with wild-type carriers. The same tendency was observed with regard to the homeostasis model assessment estimate of insulin resistance (P = 0.16). There were no differences between genotype groups with respect to measures of body composition (BMI and waist circumference). In conclusion, homozygosity of the codon 12 variant of PPAR-γ2 confers a reduced risk of the IRS among Danish Caucasian subjects.
AB - The Pro12Ala polymorphism of PPAR-γ2 has been shown to influence insulin sensitivity and the risk of type 2 diabetes in various ethnic populations. We examined whether the polymorphism was related to the insulin resistance syndrome (IRS) among nondiabetic Danish subjects. The Pro12Ala variant was examined using PCR-restriction fragment length polymorphism in a phenotypically well characterized population-based sample of 2245 nondiabetic subjects. The study participants were characterized by a number of anthropometric and biochemical measurements and the European Group for the Study of Insulin Resistance criteria enabling a classification of the study population in an IRS group and a non-IRS group. The allelic frequency of the Pro12Ala polymorphism in the total study sample was 14% (95% confidence interval, 13-15%). Two hundred ninety-four subjects fulfilled the European Group for the Study of Insulin Resistance criteria defining the IRS. The frequency of the Ala allele was 12.6% in the IRS group and 14.2% among subjects classified as not having the IRS (P = 0.15). However, the frequency of the variant in the homozygous form was significantly lower in the IRS group [0.7% (0-1.6%)] compared with the frequency in the non-IRS group [2.8% (2.1-3.5%); P = 0.02; odds ratio, 0.24 (0.06-0.99)]. Moreover, in the total study population, homozygous carriers of the variant had lower levels of fasting serum triglyceride [1.1 ± 0.4 mmol/liter (means ± SD) vs. 1.4 ± 0.9 mmol/liter; P = 0.04] and a lower diastolic blood pressure (79 ± 8 mm Hg vs. 82 ± 11 mm Hg; P = 0.01) compared with wild-type carriers. The same tendency was observed with regard to the homeostasis model assessment estimate of insulin resistance (P = 0.16). There were no differences between genotype groups with respect to measures of body composition (BMI and waist circumference). In conclusion, homozygosity of the codon 12 variant of PPAR-γ2 confers a reduced risk of the IRS among Danish Caucasian subjects.
UR - http://www.scopus.com/inward/record.url?scp=4243353569&partnerID=8YFLogxK
U2 - 10.1210/jc.87.8.3989
DO - 10.1210/jc.87.8.3989
M3 - Review
C2 - 12161548
AN - SCOPUS:4243353569
SN - 0021-972X
VL - 87
SP - 3989
EP - 3992
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 8
ER -